Wire flash
Visa acquires BioCatch for $2.4B in cash to bolster fraud detection
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
Visa announced on August 3, 2026, its $2.4 billion cash acquisition of BioCatch, an Israeli fraud intelligence provider specializing in behavioral biometrics. The deal aims to strengthen Visa's cybersecurity tools for banks and merchants amid rising AI-driven fraud, which now costs the global economy over $1 trillion annually. BioCatch protects 1.8 billion devices and 760 million users across 350+ banking clients. The acquisition is expected to close by the end of Visa's fiscal Q2 2027. On the same day, Mastercard completed its acquisition of stablecoin platform BVNK and earlier rolled out new virtual card security controls with Citi. The article compares the two companies' strategies, noting Mastercard's Recorded Future acquisition (2024) as a competitive advantage. Visa's value-added services revenue grew 34% last quarter, while Mastercard's rose 20%. Hedge fund ownership shifted slightly in Mastercard's favor. Visa trades at a forward P/E of 24.45 vs. Mastercard's 29.15.
Source report
Maham Fatima Thu, August 6, 2026 at 3:15 PM PDT | 4 min read
- V
- MA
Visa (NYSE: V) announced on August 3 that it would acquire fraud intelligence provider BioCatch for $2.4 billion in cash, marking its latest move to strengthen cybersecurity tools for the banks and merchants operating on its network. The deal targets a growing global problem: account takeovers and scams now cost the global economy more than $1 trillion annually, and Visa warns that AI is enabling fraudsters to execute attacks at a scale banks have not previously encountered.
The Bull Case: Closing the Fraud-Tech Gap
BioCatch, founded in 2011 in Tel Aviv, built its business on behavioral biometrics—tracking keystrokes, touch gestures, and device handling to distinguish real customers from fraudsters in real time. The company already protects:
- 1.8 billion devices
- 760 million users
- More than 350 banking clients across 21 countries
Under Permira's ownership since 2024, BioCatch's revenue and gross profit both roughly tripled. Integrating this technology into Visa's network—which connects nearly 14,500 financial institutions and processes over 329 billion transactions worth more than $17 trillion annually—gives the platform a significantly larger stage.
The deal also addresses a gap investors had been monitoring. Evercore analyst Adam Frisch noted that the market would welcome the news, as many had identified Mastercard's Recorded Future as the best-in-class tool in this category. Visa has now invested substantially to catch up, building on more than $13 billion spent on technology and infrastructure to combat fraud over the past five years, including its 2024 purchase of Featurespace.
Andrew Torre, Visa's president of value-added services, stated that BioCatch will help clients stop fraud before it reaches the point of payment. This division grew revenue 34% last quarter, making it the fastest-growing part of Visa's business.
The Bear Case: The Clock and the Competition
The timeline undermines the urgency of the pitch. The BioCatch deal is not expected to close until the end of Visa's fiscal second quarter of 2027, leaving the gap Frisch described open for months while Mastercard's Recorded Future—acquired for $2.65 billion in 2024—continues operating.
On the same day Visa announced the BioCatch purchase, Mastercard (NYSE: MA) completed its own acquisition of stablecoin infrastructure platform BVNK. On July 23, Mastercard also rolled out new issuer and clearing controls across its virtual card network, with Citi as the first bank live on both platforms.
Visa's underlying business still operates at a wider margin and a slightly higher cross-border volume growth rate (13% to Mastercard's 12%) last quarter. However, Mastercard continues to build strong momentum elsewhere, led by a 20% jump in value-added services revenue. None of this is derailed by a single acquisition, and $2.4 billion in cash still requires regulatory clearance before it can impact either company's fraud metrics.
Market Sentiment: Visa vs. Mastercard
Both card networks are relying on acquisitions to simultaneously build out their security and infrastructure stacks. Mastercard completed its BVNK stablecoin deal as Visa announced BioCatch, and its virtual card security push landed two weeks earlier. Investors are therefore pricing two companies making parallel bets rather than one chasing the other.
| Metric | Visa | Mastercard | |--------|------|------------| | Hedge fund ownership (last quarter) | 184 → 181 funds | 150 → 157 funds | | Forward P/E (as of August 4) | 24.45 | 29.15 | | Short interest (% of float) | 1.39% | 1.04% |
The split in institutional conviction favors Mastercard's momentum. With Mastercard trading at a higher forward P/E, the market is asking it to prove more growth.
Conclusion
The BioCatch deal gives Visa a meaningful position in fraud prevention at a time when its cross-border and value-added services businesses are already growing strongly. Mastercard's recent earnings growth has outpaced Visa's, but the $2.4 billion acquisition still needs to demonstrate that AI fraud detection can deliver measurable results before the deal closes in 2027.
Source
Yahoo FinanceWestern
Part of this Story
Visa Acquires BioCatch for $2.4 Billion to Combat AI Fraud